Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rousselot is a global leader in collagen-based solutions and the manufacturer of the Peptan brand of bioactive collagen peptides. As a subsidiary of Darling Ingredients, the company specializes in the development and production of high-quality gelatin and collagen for the pharmaceutical, food, and nutrition industries. Peptan, their flagship product line, is widely used in supplements and functional foods to support joint health, skin elasticity, and muscle recovery. Rousselot maintains a strong focus on scientific research, conducting numerous clinical trials to substantiate the health benefits of its collagen ingredients. The company operates a global network of manufacturing plants and R&D centers to serve customers in over 75 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Peptan.